{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:50:52Z","timestamp":1791247852137,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jhepr.2026.101954","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:32:53Z","timestamp":1783351973000},"page":"101954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A risk-based post-ablation follow-up strategy for hepatocellular carcinoma"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5617-9308","authenticated-orcid":false,"given":"Daopeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-3158","authenticated-orcid":false,"given":"Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6770-654X","authenticated-orcid":false,"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-3079","authenticated-orcid":false,"given":"Zixiong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101954_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2026.101954_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhepr.2026.101954_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2026.101954_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in Oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jhepr.2026.101954_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Vogel","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhepr.2026.101954_bib7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.14309\/ajg.0000000000002774","article-title":"Recommended 10-year follow-up strategy for small hepatocellular carcinoma after radiofrequency ablation: a cost-effectiveness evaluation","volume":"119","author":"Chen","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101954_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5009\/gnl20101","article-title":"Change in the recurrence pattern and predictors over time after complete cure of hepatocellular carcinoma","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2026.101954_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v077.i01","article-title":"Ranger: a fast implementation of random forests for high dimensional data in C++ and R","volume":"77","author":"Wright","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jhepr.2026.101954_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101954_bib11","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.223091","article-title":"Predicting infectious complications after percutaneous thermal ablation of liver malignancies: a 12-year single-center experience","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2026.101954_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2468-1253(18)30029-3","article-title":"Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial","volume":"3","author":"Vietti Violi","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib13","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70344","article-title":"Machine learning model based on prognostic nutritional index for predicting long-term outcomes in patients with HCC undergoing ablation","volume":"13","author":"Zhang","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.jhepr.2026.101954_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/biostatistics\/kxu010","article-title":"Random survival forests for competing risks","volume":"15","author":"Ishwaran","year":"2014","journal-title":"Biostatistics"},{"key":"10.1016\/j.jhepr.2026.101954_bib16","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1038\/s41467-020-17672-w","article-title":"An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101954_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.34601","article-title":"A risk-based postresection follow-up strategy for hepatocellular carcinoma patients","volume":"129","author":"Fu","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2026.101954_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JS9.0000000000000827","article-title":"An optimized postsurgery follow-up strategy for patients with esophageal cancer: a cohort study","volume":"110","author":"Mai","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhepr.2026.101954_bib19","unstructured":"Yang D., Lin K., Yang Y., et al., Proposed follow-up schedules. http:\/\/fahultrasound.site:8622\/pafah."},{"key":"10.1016\/j.jhepr.2026.101954_bib20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1186\/s12885-018-5069-z","article-title":"Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2026.101954_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cgh.2020.06.072","article-title":"Surveillance and monitoring of hepatocellular carcinoma during the COVID-19 pandemic","volume":"19","author":"Mehta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib23","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232369","article-title":"Liver imaging reporting and data system contrast-enhanced US nonradiation treatment response assessment version 2024","volume":"311","author":"Lyshchik","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2026.101954_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","article-title":"Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors","volume":"58","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101954_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","article-title":"Microwave ablation for hepatic malignancies: a multiinstitutional analysis","volume":"259","author":"Groeschl","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2026.101954_bib26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.21037\/tcr-23-1939","article-title":"Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis","volume":"13","author":"Xiong","year":"2024","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jhepr.2026.101954_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00270-011-0293-9","article-title":"Serum gamma-glutamyl-transferase independently predicts outcome after transarterial chemoembolization of hepatocellular carcinoma: external validation","volume":"35","author":"Guiu","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhepr.2026.101954_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.hpb.2016.05.011","article-title":"Liver function declines with increased age","volume":"18","author":"Cieslak","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhepr.2026.101954_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40644-020-00319-w","article-title":"Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification","volume":"20","author":"Sun","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.jhepr.2026.101954_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ejrad.2015.04.020","article-title":"Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: comparison with primary cases","volume":"84","author":"Fukuhara","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhepr.2026.101954_bib31","article-title":"A hepatocellular cancer patient-derived organoid xenograft model to investigate impact of liver regeneration on tumor growth","volume":"204","author":"Haak","year":"2024","journal-title":"J Vis Exp"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:52:32Z","timestamp":1791244352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589555926002259"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101954","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A risk-based post-ablation follow-up strategy for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101954"}}